The settlement is one of a few that the company has made within the past several months.
Agency sanctions include a monetary penalty and revocation of the lab’s CLIA certificate.
Should your IDE device be reimbursed? FDA’s latest draft guidance will help CMS make the decision.
In a Today Show interview, Elizabeth Holmes voices responsibility felt as a result of company problems.
What can we learn about how new technologies become eligible for additional payment?
Payer organizations face a host of issues in the conversion to ICD-10.
Billing in clinical trials has changed recently, so here is a summary of where it has been and where it is heading.